台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP070: Identification of urothelial cancer mutations by targeted deep sequencing of plasma DNA

2019-07-07 • 觀看: 1474 • 回應: 0 • doc
MP069: The results of combined radiation therapy and hormonal therapy in the treatment of lymph node-positive prostate cancer: experience of a single institution

2019-07-07 • 觀看: 1383 • 回應: 0 • doc
MP068: Intravesical hyaluronic acid instillation in the treatment of radiation-induced hemorrhagic cystitis in Taipei city hospital experience

2019-07-07 • 觀看: 1616 • 回應: 0 • doc
MP067: Outcomes of robot-assisted radical prostatectomy in men with previous transurethral resection of prostate

2019-07-07 • 觀看: 1442 • 回應: 0 • doc
MP066: Infection after transrectal ultrasound-guided prostate biopsy - rate and contributing factors at a regional hospital

2019-07-07 • 觀看: 1400 • 回應: 0 • doc
MP065: The association between androgen deprivation therapy and the risk of tenosynovitis

2019-07-07 • 觀看: 1450 • 回應: 0 • doc
MP064: Association of prostate cancer with 5-alpha reductase as Finasteride and Dutasteride.

2019-07-07 • 觀看: 1555 • 回應: 0 • doc
MP063: Prostate-specific antigen testing related to rising incidence of prostate cancer

2019-07-07 • 觀看: 1474 • 回應: 0 • doc
MP062: Elucidation of the therapeutic role of nuclear respiratory factor-1 in the regulation of prostate cancer

2019-07-07 • 觀看: 1387 • 回應: 0 • doc
MP061: The relationship of prostate health index (PHI) and PSA based on the age group in CMUH experience

2019-07-07 • 觀看: 1523 • 回應: 0 • doc
MP060: Outcome of lymph node dissection in renal pelvis urothelial carcinoma

2019-07-07 • 觀看: 1689 • 回應: 0 • doc
MP059: The clinical significance of tumor size and preoperative systemic immune-inflammation index (SII) in oncologic outcomes in patients with upper tract urothelial carcinomas (UTUC)

2019-07-07 • 觀看: 1428 • 回應: 0 • doc

Prev
731
732
733
734
735
736
737
738
739
740
Next
/ 1052